Liver fibrosis is characterized as the repeated injury causing the remodeling of the liver tissue resulting in the excessive accumulation of extracellular matrix with scar tissue encapsulating the area of injury.\[[@ref1]\] This condition resulted in many clinical complications, such as ascites, variceal hemorrhage, and encephalopathy.\[[@ref2]\] Different diseases, such as Wilson\'s disease, viral hepatitis B and C (HBV and HCV), liver cancer, and cirrhosis can affect the liver. Carbon tetrachloride (CCl~4~) has been widely used to induce liver fibrosis in experimental animals. The mechanism involves the addition of one electron to CCl~4~ on binding to ferric cytochrome P450 and cleaving of the carbon--chloride bond. This binding results in a highly reactive trichloromethyl free radical and causes liver cell necrosis and destruction of the extracellular matrix through lipid peroxidation of membranes.\[[@ref3]--[@ref5]\]

The nonhematopoietic part of the bone marrow, referred to as bone marrow-derived mesenchymal stem cells (BMSCs), are of interest because of the simple isolation from a small aspirate of bone marrow.\[[@ref6]\] BMSCs have shown a large *in vitro* and *in vivo* differentiation potential.\[[@ref7]\] Their hepatic potential was first described by Lee *et al*.\[[@ref8]\] Some recent studies also evidenced *in vivo* potential of BMSCs.\[[@ref9]\] A key advantage of using BMSCs is their immunologic properties.\[[@ref10]\] They were first shown to be engrafted in the recipient\'s liver and differentiated into hepatocytes by Petersen *et al*.\[[@ref11]\] Therefore, BMSCs can be a useful source for cellular therapy in treating liver fibrosis.\[[@ref12]\]

BMSCs could repair CCl~4~ -injured liver by reducing inflammation, collagen deposition, and remodeling.\[[@ref13]\] Sakaida *et al*\[[@ref14]\] found that BMSCs treatment to 4-week CCl~4~ -induced rats would result in significantly reduced liver fibrosis. A study by Oh *et al*\[[@ref15]\] found that two of the liver-specific proteins alfa-feto protein and albumin were expressed in rat bone marrow cell culture. Some other studies also reported that BMSCs can express albumin in *in vitro* conditions.\[[@ref16]--[@ref18]\] In this present study, green fluorescent protein (GFP)^+^ BMSCs were transplanted into CCl~4~ -induced liver fibrotic mouse model. The co-expression of albumin in the GFP^+^ BMSCs was observed in CCl~4~ -induced liver after 2 and 4 weeks of BMSCs transplantation. After 4 weeks, transplanted GFP^+^ BMSCs showed increased expression of albumin and a significant reduction in fibrosis was observed.

PATIENTS AND METHODS {#sec1-1}
====================

Mice {#sec2-1}
----

GFP-transgenic mice and C57BL/6 wild-type mice were used in the experiment. All animals were treated according to procedures approved by the Institutional Review Board at the National Center of Excellence in Molecular Biology, Lahore, Pakistan. All animals were housed in conventional cages under controlled conditions of temperature (23°C ± 3°C) and relative humidity (50% ± 20%), with light illumination for 12 h/day.

BMSCs preparation {#sec2-2}
-----------------

For BMSCs isolation, GFP-transgenic mice (6 weeks old) were killed and the limbs were removed. BMSCs were flushed with Dulbecco\'s Modified Eagle Medium (DMEM) from the medullary cavities of tibias and femurs using a 25-G needle. Then cells were cultured in DMEM medium supplement with 20% FBS (Sigma, USA), 100 μg/mL streptomycin and 100 U/mL penicillin in a 25 cm^2^ culture flasks and incubated at 37°C in an atmosphere containing 5% CO~2~ . When cell confluency reached to 70--80%, they were detached with 0.25% Trypsin and 0.1% EDTA, and subcultured in two 25 cm^2^ flasks till second passage.

Experimental protocol {#sec2-3}
---------------------

Six weeks old female C57BL/6 mice were treated with 1 ml/ kg CCl~4~ dissolved in olive oil (1:1) twice a week for 4 weeks intraperitoneally.\[[@ref14]\] Animals were divided into 3 groups (*n* = 10 each); CCl~4~ control group, BMSCs transplanted group sacrificed after 2 weeks and BMSCs transplanted group sacrificed after 4 weeks. Twenty-four hours after the last injection of CCl~4~, 1 × 10^5^ GFP^+^ BMSCs were injected directly into liver as described previously.\[[@ref19]\] Same volume of saline water was injected in CCl~4~ control animals. After 2 and 4 weeks of post-transplantation, mice were sacrificed to assess the extent of liver fibrosis and expression of albumin. All mice were kept on receiving CCl~4~ during the post-transplantation period.

Histology of liver tissue {#sec2-4}
-------------------------

The liver was perfused via the heart with 4% paraformaldehyde to flush out blood cells and incubated with 4% paraformaldehyde overnight. Tissues were then soaked in 30% sucrose for 3 h and frozen in liquid nitrogen to prepare for sectioning. Cells expressing albumin and αSMA were analyzed by immunohistochemistry using anti-albumin (1:50; Abcam, USA) and anti-αSMA antibodies (1:400; Sigma--Aldrich, Germany). Tissues were soaked in 0.3% Triton X-100 with 2% normal goat serum (Chemi-Con, Temecula, CA, USA). Sections were incubated with primary antibodies overnight at 4°C. For fluorescent immunohistochemistry, we used fluorescein isothiocyanate--conjugated anti-mouse as secondary antibody. For the evaluation of fibrosis, picro-sirius red staining was performed using 0.1% picro-sirius red solution as previously described. Fluorescence images were taken by Olympus BX61 microscope equipped with DP-70 camera (Olympus, Japan).

Quantitative analysis of liver fibrosis {#sec2-5}
---------------------------------------

We quantified the liver fibrosis area with picro-sirius red staining using an Olympus microscope equipped with a DP-70 camera (Tokyo, Japan). Briefly, the red area, considered the fibrotic area, was assessed by computer-assisted image analysis with Image J software (NIH). The mean value of 3 randomly selected areas per sample was used as the expressed percent area of fibrosis.

Gene expression analysis {#sec2-6}
------------------------

RNA from liver tissue of all experimental groups was extracted using TRIZOL reagent (Invitrogen, Carlsbad, CA, USA). cDNA was synthesized using 1μg of total RNA by Revert Aid H Minus first strand cDNA synthesis kit (Fermentas, Glen Burnie, Maryland, USA). Gene-specific primers were designed using online software Primer3 (<http://frodo.wi.mit.edu/primer3/>). Sequences of the genes were taken from NCBI. All primer sequences are mentioned in [Table 1](#T1){ref-type="table"} and following thermal conditions: 4 min at 94°C, followed by 31--35 cycles of 94°C for 45 s, 56--58°C for 45 s, and 72°C for 45 s, then final extension at 72°C for 10 min. PCR products were visualized and photographed after electrophoresis in 2% (w/v) agarose gels containing 0.5 mg/ mL ethidium bromide.

###### 

Primer sequences

![](SJG-18-263-g001)

Statistical analysis {#sec2-7}
--------------------

Quantitative data of percent fibrosis area and cells expressing albumin of 10 animals was obtained. Results are presented as the mean ± SD. Differences between groups were analyzed by One-way analysis of variance.

RESULTS {#sec1-2}
=======

Mice chronically infected with CCl~4~ were treated with GFP^+^ BMSCs by injecting into the left lateral lobe of the liver. Bright GFP^+^ cells were engrafted and observed in all lobes of the liver, indicating cell migration from left lateral lobe to other injury sites as well \[[Figure 1b](#F1){ref-type="fig"}\] as compared to non-transplanted mice \[[Figure 1a](#F1){ref-type="fig"}\]. GFP^+^ cells in mice sacrificed after 2 weeks co-expressed albumin in the hepatic parenchyma \[[Figure 2b](#F2){ref-type="fig"}\]. Later at 4^th^ week, the transplanted sections expressed GFP^+^ cells with enhanced expression of albumin \[[Figure 2c](#F2){ref-type="fig"}\]. GFP^+^ albumin expressing cells were not present in the fibrotic mouse liver transplanted with saline water \[[Figure 2a](#F2){ref-type="fig"}\]. Statistical data \[[Figure 2d](#F2){ref-type="fig"}\] showed that BMSCs transplanted liver showed significantly higher number of cells expressing albumin (60 cells/field) after 4 weeks of BMSCs transplantation as compared with other groups (22 cells/field in BMSCs 2 weeks group).

![Homing of transplanted GFP+ BMSCs in CCl~4~ (a) and BMSCs (b) groups. DAPI was used to identify nuclei (magnification = 200×; *n* = 10 each)](SJG-18-263-g002){#F1}

![Immunohistochemical expression of albumin in mouse liver. (a) CCl~4~ group, (b) BMSCs transplanted group sacrificed after 2 weeks, (c) BMSCs transplanted group sacrificed after 4 weeks (original magnification = 200×), (d) one-way analysis of variance was applied to check the significance of the data (*n* = 10). All values are expressed as mean ± SEM. \**P* \< 0.05 for BMSCs 4 weeks vs CCl4 control, \#*P* \< 0.05 for BMSCs 4 weeks vs BMSCs 2 weeks, Φ*P* \< 0.05 for BMSCs 2 weeks vs CCl~4~ control](SJG-18-263-g003){#F2}

Fluorescence staining (anti-α smooth muscle actin with green color) indicated that a fine network pattern of stellate cells existed in the liver treated with CCl~4~ alone \[[Figure 3a](#F3){ref-type="fig"}\]. Conversely, GFP^+^ BMSCs transplanted groups showed reduced expression of αSMA in fibrotic liver \[Figure [3b](#F3){ref-type="fig"} and [c](#F3){ref-type="fig"}\]. Mice sacrificed after 4 weeks of BMSCs transplantation showed significantly reduced expression of αSMA as compared with other groups \[[Figure 3c](#F3){ref-type="fig"}\].

![Immunohistochemical expression of αSMA in fibrotic mouse. (a) CCl~4~ group, (b) BMSCs transplanted group sacrificed after 2 weeks (c) BMSCs transplanted group sacrificed after 4 weeks. Considerable reduction in the expression of αSMA can be observed (original magnification = 200×)](SJG-18-263-g004){#F3}

After 4 weeks, the BMSCs transplanted liver clearly showed reduction of liver fibrosis compared to the group treated with CCl~4~ alone and BMSCs transplanted groups \[Figure [4a](#F4){ref-type="fig"}--[c](#F4){ref-type="fig"}\]. Quantitative analysis \[[Figure 4d](#F4){ref-type="fig"}\] of liver fibrosis by Image J software indicated that the percent fibrotic area of liver after 4 weeks of BMSCs transplantation was significantly reduced to 1.17% ± 0.34% as compared to other groups (2.35% ± 0.66 = BMSCs 2 weeks group and 4.56% ± 1.75 = CCl~4~ group). The reverse transcriptase PCR (RT-PCR) analysis showed reduction in the expression of αSMA and collagen 1α1 genes after 4 weeks of BMSCs transplantation while the expression of these genes was increased after CCl~4~ injury. MMP-9 is known to be an antifibrotic marker released by BMSCs.\[[@ref20]\] After BMSCs transplantation the expression of MMP-9 was noted to increase along with albumin, which is a hepatic functional marker \[[Figure 5](#F5){ref-type="fig"}\].

![Photomicrographs of liver sections stained with sirius red. (a) CCl~4~ group, (b) BMSCs transplanted group sacrificed after 2 weeks, (c) BMSCs transplanted group sacrificed after 4 weeks (original magnification = 200×), (d) quantitative analysis of fibrosis in different experimental groups. One-way analysis of variance was applied to check the significance of the data (*n* = 10 each group). All values are expressed as mean ± SEM. \**P* \< 0.05 for BMSCs 4 weeks vs CCl4 control, \#*P* \< 0.05 for BMSCs 4 weeks vs BMSCs 2 weeks, Φ*P* \< 0.05 for BMSCs 2 weeks vs CCl~4~ control](SJG-18-263-g005){#F4}

![RT-PCR analysis of fibrotic (αSMA, collagen 1α1), antifibrotic (MMP-9), and hepatic (albumin) genes following the BMSCs transplantation in CCl~4~-injured mouse liver after 2 and 4 weeks post-transplantation](SJG-18-263-g006){#F5}

DISCUSSION {#sec1-3}
==========

In this study, CCl~4~ -induced liver fibrosis was ameliorated after transplantation of BMSCs. BMSCs could ameliorate liver fibrosis by expressing certain antifibrotic factors, such as MMP-9\[[@ref18]\] and also by releasing some factors, such as soluble Kit-ligand related to the differentiation and proliferation of transplanted BMSCs in liver inflammation induced by continuous injection of CCl~4~ .\[[@ref14]\] BMSCs secrete certain growth factors, such as hepatic growth factor (HGF), nerve growth factor (NGF), and many cytokines. These have antiapoptotic activity in hepatocytes and play an essential part in the regeneration of liver.\[[@ref21][@ref22]\]

MMP-9 was reported to have a role in the migration of BMSCs to the inflammatory site.\[[@ref23]\] Transplanted BMSCs resulting in the degradation of the extracellular matrix may presumably lead to improved liver function and better survival of mice. According to our present data, increased expression of GFP^+^ cells at the site of liver injury contributed to the degradation of interstitial collagens, which has been shown by cirius red staining \[[Figure 4](#F4){ref-type="fig"}\]. This collagen is degraded to gelatin, which was degraded by *MMP-9* resulting in the regression of fibrosis.\[[@ref24]\] Our study indicated an enhanced expression of MMP-9 \[[Figure 5](#F5){ref-type="fig"}\] and reduced collagen deposition \[[Figure 4](#F4){ref-type="fig"}\] after BMSCs transplantation.

The expression of αSMA, which is a marker of activated hepatic stellate cells, was reduced significantly after 4 weeks of GFP^+^ BMSCs transplantation \[Figures [3](#F3){ref-type="fig"} and [5](#F5){ref-type="fig"}\]. Thus, transplanted BMSCs may affect activated stellate cells by inhibiting them or by leading them to apoptosis.\[[@ref25]\] Collagen lαl, another fibrotic factor produced by activated hepatic stellate cells, was accumulated after CCl~4~ -induced fibrotic liver injury. Our results indicated a reduced. RNA expression of *collagen* *I*α*I* gene after 4 weeks of BMSCs transplantation compared with the liver treated with CCl~4~ alone. These results are in line with those of Sakaida *et al*\'s.\[[@ref14]\]

Fang *et al*.\[[@ref13]\] reported that albumin-positive donor-derived cells were found at a lower frequency in CCl~4~ -injured liver tissue. Some other studies reported an increase in the serum albumin level.\[[@ref26][@ref27]\] In the current study, the expression of albumin was observed along with GFP^+^ BMSCs, indicating that albumin is expressed by the transplanted BMSCs \[Figures [1](#F1){ref-type="fig"} and [2](#F2){ref-type="fig"}\]. RT-PCR analysis also showed a marked increase in the expression of *albumin* after 4 weeks of BMSCs transplantation \[[Figure 5](#F5){ref-type="fig"}\].

The present study clearly indicates that BMSCs express albumin when transplanted to CCl~4~ -induced fibrotic liver. This study reveals that BMSCs ameliorate CCl~4~ -induced liver injury in mice by reducing fibrosis, expressing liver-specific genes, downregulating the expression of profibrotic genes, and upregulating antifibrotic and hepatic genes. In conclusion, the present study strengthens the concept of cellular therapy for the treatment of liver fibrosis.
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